What is the appropriate workup for a male patient presenting with hematuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Hematuria in Male Patients

The appropriate workup for a male patient presenting with hematuria should include risk stratification, urinalysis, serum PSA testing, appropriate imaging, and cystoscopy based on risk factors. 1

Initial Risk Assessment

Risk stratification is essential to guide the extent of evaluation:

Risk Factors for Urologic Malignancy

  • Age >60 years
  • Smoking history
  • Exposure to industrial chemicals
  • Family history of renal cell carcinoma or genetic renal tumor syndrome
  • Degree of hematuria (gross hematuria carries highest risk)

Diagnostic Evaluation Algorithm

Step 1: Confirm Hematuria

  • Urinalysis to confirm presence of red blood cells
  • Determine if microscopic (≥3-5 RBCs/HPF) or gross hematuria
  • Assess for pyuria, bacteriuria, crystals, and casts

Step 2: Basic Laboratory Tests

  • Complete metabolic panel (BUN, creatinine, electrolytes)
  • Serum PSA measurement in men with at least a 10-year life expectancy 2
  • Urine culture to rule out infection

Step 3: Imaging Based on Risk

  • Low-Risk Patients (age ≤40, <5 RBCs/HPF, no risk factors):

    • Renal ultrasound
    • Repeat urinalysis in 3 months
  • Intermediate/High-Risk Patients (age >40, ≥5 RBCs/HPF, or risk factors present):

    • CT urography (92% sensitivity, 93% specificity) 1
    • Alternative options if CT contraindicated:
      • MR urography (renal insufficiency or contrast allergy)
      • Renal ultrasound (younger patients)

Step 4: Cystoscopy

  • Recommended for all patients with:
    • Gross hematuria
    • Age >40 with microscopic hematuria
    • Risk factors for urologic malignancy
    • Persistent unexplained hematuria

Step 5: Additional Testing Based on Clinical Suspicion

  • Urine cytology for patients with:
    • Irritative voiding symptoms
    • Risk factors for carcinoma in situ 1
  • Consider prostate biopsy if prostate cancer is suspected 2

Special Considerations

Benign Prostatic Hyperplasia (BPH)

  • Common cause of hematuria in older men
  • Digital rectal examination to assess prostate size
  • Consider PSA testing as it may predict natural history of BPH 2

Acute Management

  • For patients with gross hematuria and clots:
    • Consider continuous bladder irrigation
    • Monitor for urinary retention 3

Follow-up Recommendations

  • Patients with negative initial evaluation should have repeat urinalysis within 12 months
  • Persistent microscopic hematuria requires continued surveillance
  • Consider nephrology referral if there is:
    • Significant proteinuria
    • Elevated creatinine
    • eGFR <60 ml/min/1.73m² 1

Common Pitfalls to Avoid

  1. Do not attribute hematuria to anticoagulant therapy without proper evaluation - these patients still require complete workup 1

  2. Do not assume hematuria is due to UTI without supporting evidence of infection (pyuria, positive culture) 1

  3. Do not ignore clinical changes such as new symptoms, gross hematuria, or increased degree of microscopic hematuria, as these should prompt immediate re-evaluation 1

  4. Do not delay urologic referral for patients with gross hematuria, as the risk of malignancy exceeds 10% 4

  5. Do not forget to consider non-urological causes of hematuria, including nephropathies, which may require nephrology consultation 5

By following this structured approach, clinicians can ensure appropriate evaluation of male patients presenting with hematuria, focusing on identifying potentially serious underlying conditions while avoiding unnecessary testing in low-risk individuals.

References

Guideline

Evaluation and Management of Microscopic Hematuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Macroscopic haematuria--a urological approach.

Australian family physician, 2013

Research

Hematuria.

Primary care, 2019

Research

What is significant hematuria for the primary care physician?

The Canadian journal of urology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.